Prot #516-001: A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Project: Research project

Project Details

StatusActive
Effective start/end date12/12/1612/12/22

Funding

  • Clinverse, Inc. (Prot #516-001)
  • Mirati Therapeutics Inc. (Prot #516-001)